ARGL yields 2000000.00% · ABBV yields 3.06%● Live data
📍 ARGL pulled ahead of the other in Year 1
Combined, ARGL + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ARGL + ABBV for your $10,000?
Argyle Security, Inc., a detention and commercial security provider, engages in designing and integrating electronic security solutions in the United States. It operates through ISI, MCS, PDI, Com-Tec, and MCS Fire & Security business units. The ISI business unit designs, engineers, supplies, installs, and maintains an array of detention systems and equipment that include detention hardware, such as prison bars, locks, and locking systems; security glass; security furniture comprising metal furniture; detention grade hollow metal doors; frames; and windows and related accessories. Its customers include general contractors and governmental or private entities. The MCS business unit is involved in the design, engineering, supply, installation, and maintenance of complex electronic security systems for correctional facilities. This business unit provides access and door controls, intercoms, closed circuit television, and software for command center controls and intrusion perimeter systems primarily to the general contractors. The PDI business unit manufactures high security metal barriers, high security observation window systems, wire mesh, bar grating, detention furniture, and accessories. The Com-Tec business unit designs electronic security and communications systems and provides touch screen controls, UL 508A control panels, door and gate controls, closed circuit televisions, intercom and paging, security management, access control, and perimeter intrusion detection systems. The MCS Fire & Security business unit designs, engineers, supplies, installs, and maintains professional security, access control, video and fire alarm, closed circuit television, sound paging systems, and structured cabling primarily for petro-chemical, healthcare, utilities, and education customers. The company was formerly known as Argyle Security Acquisition Corporation. Argyle Security, Inc. was founded in 2005 and is headquartered in San Antonio, Texas.
Full ARGL Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.